Parkinson’s Disease – Drug Pipeline Landscape, 2022 |1ST Biotherapeutics Inc, 2N Pharma ApS, 3Z ehf, 4D Pharma Plc, Abaxys Therapeutics SA, AbbVie, Abfero Pharmaceuticals Inc, ABL Bio Inc

Global Insight Services have recently published a report on Parkinson’s Disease Pipeline landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.

Parkinson’s Disease (PD) simply called as Parkinson’s, is a progressive neuro-degenerative disorder which mainly affects the motor systems due to the depletion in dopamine. The motor symptoms result from the death of cells in the substantia nigra leading to dopamine deficit. The cause of cell death involves the build-up of misfolded proteins into Lewy bodies in the neurons. Collectively known as Parkinsonian Syndrome.

The main cause of PD is not known. The environmental triggers, genetics are the associated factors in the cause of PD. Pesticides, herbicides and proximity to industrial plants, drugs are linked to the cause. The oxidation and generation of free radicals may be the cause of damage of thalamic nuclei.

The symptoms will slowly emerge. Early symptoms are tremors I hands, arms, legs and face, rigidity, slowness in the movement, difficulty walking, impaired balance and coordination. Other symptoms associated with cognitive and behavioural problems including depression, anxiety and apathy.

Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31073

Report Highlights

Global Insight Service’s, Parkinson’s Disease – Drug Pipeline Landscape, 2022 report provides an overview of the Parkinson’s Disease pipeline drugs. This report covers detailed insights on Parkinson’s Disease drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Parkinson’s Disease pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Ask For Customization :  https://www.globalinsightservices.com/request-customization/GIS31073

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.

Report Segmentation
  • Assessment by Stage of Development
  • Assessment by Companies
  • Assessment by Target
  • Assessment by Mechanism of Action
  • Assessment by Molecule Type
  • Assessment by Route of Administration

Some of the key players involved in development of Parkinson’s Disease therapeutics are :

• 1ST Biotherapeutics Inc
• 2N Pharma ApS
• 3Z ehf
• 4D Pharma Plc
• Abaxys Therapeutics SA
• AbbVie
• Abfero Pharmaceuticals Inc
• ABL Bio Inc
• AC Immune SA
• Accure Therapeutics SL
• AceLink Therapeutics Inc
• Acelot Inc
• AcureX Therapeutics Corp
• Addex Pharma SA
• Adhera Therapeutics Inc
• Adicet Bio Inc
• Aeterna Zentaris Inc
• AevisBio Inc
• AgoneX Biopharmaceuticals Inc

Buy this report:  https://www.globalinsightservices.com/checkout/single_user/GIS31073

With Global Insight Services, you receive:

  • 10-year forecast to help you make strategic decisions
    • In-depth segmentation which can be customized as per your requirements
    • Free consultation with lead analyst of the report
    • Excel data pack included with all report purchases
    • Robust and transparent research methodology

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/